[Portfolio]

Diagnostics

Companies

We focus on biomedical technology companies developing next-generation drugs, devices and diagnostics, data, tools, and healthcare services and work closely with each portfolio company to build and grow the business from inception to exit.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Bayesian Health
Private Equity
Diagnostics
Private
No
US
Freenome
Private Equity
Co-Investments
Diagnostics
Private
No
US
Haystack Oncology
Exit in 2023
Private Equity
Structured Opportunities
Co-Investments
Diagnostics
Exited
Yes
US
Personal Genome Diagnostics (PGDx)
Exit in 2022
Private Equity
Diagnostics
Exited
No
US
Pillar Biosciences
Exit in 2024
Structured Opportunities
Diagnostics
Exited
No
US
Pink Dx
Private Equity
Diagnostics
Private
No
US
PrognomiQ
Private Equity
Diagnostics
Private
No
US
Sherlock Biosciences
M&A in 2025
Private Equity
Diagnostics
Exited
No
US
Sickbay
Private Equity
Structured Opportunities
Diagnostics
Private
No
US
Sunbird Bio
Private Equity
Diagnostics
Private
No
US
TapestryHealth
Structured Opportunities
Diagnostics
Private
No
US
Thrive Earlier Detection
Exit in 2020
Private Equity
Co-Investments
Diagnostics
Exited
No
US
Xilis, Inc.
Private Equity
Diagnostics
Private
No
US